Answers are grounded in this paper and cite their sources.
Most breast cancers require neoadjuvant chemotherapy and the response to primary systemic therapy (PST) is crucial for deciding on the surgical technique and predicting patient outcomes. However, chemotherapy also brings numerous side effects, with cardiovascular issues being some of the most significant, common and challenging to manage.
No takes yet. Share an insight, caveat, or question.
Popa et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: